Trevena (TRVN) Short Interest Ratio & Short Volume → **Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! (From Huge Alerts) (Ad) Free TRVN Stock Alerts $0.40 0.00 (0.00%) (As of 05/20/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Trevena Short Interest DataCurrent Short Interest15,100 sharesPrevious Short Interest58,900 sharesChange Vs. Previous Month-74.36%Dollar Volume Sold Short$6,040.00Short Interest Ratio0.1 Days to CoverLast Record DateApril 30, 2024Outstanding Shares18,340,000 sharesFloat Size17,880,000 sharesShort Percent of Float0.08%Today's Trading Volume26,441 sharesAverage Trading Volume159,979 sharesToday's Volume Vs. Average17% Short Selling Trevena ? Sign up to receive the latest short interest report for Trevena and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTRVN Short Interest Over TimeTRVN Days to Cover Over TimeTRVN Percentage of Float Shorted Over Time Ad The Freeport SocietyNext President (Not Trump. Not Biden.)Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be Trump.Click here to see why it will be ______ _________. Trevena Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202415,100 shares $6,040.00 -74.4%0.1%0.1 $0.40 4/15/202458,900 shares $23,053.46 -47.8%0.3%0.3 $0.39 3/31/2024112,800 shares $51,888.00 +54.5%0.6%0.9 $0.46 3/15/202473,000 shares $40,150.00 -10.8%0.4%0.6 $0.55 2/29/202481,800 shares $47,525.80 +117.6%0.5%0.7 $0.58 2/15/202437,600 shares $22,360.72 -14.2%0.2%0.3 $0.59 Get the Latest News and Ratings for TRVN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Trevena and its competitors with MarketBeat's FREE daily newsletter. 1/31/202443,800 shares $27,725.40 +52.6%0.3%0.4 $0.63 1/15/202428,700 shares $19,805.87 -59.9%0.2%0.2 $0.69 12/31/202371,500 shares $51,630.15 -75.1%0.5%0.6 $0.72 12/15/2023286,800 shares $169,212.00 -41.8%2.1%0.9 $0.59 11/30/2023493,000 shares $286,827.40 -14.0%3.4%1.5 $0.58 11/15/2023573,000 shares $338,184.60 -18.2%3.9%0.7 $0.59 10/31/2023700,300 shares $373,540.02 +3.2%5.2%0.9 $0.53 10/15/2023678,400 shares $379,904.00 -14.3%5.1%0.8 $0.56 9/30/2023791,100 shares $477,033.30 -30.0%5.9%1 $0.60 9/15/20231,130,000 shares $791,000.00 +207.5%8.4%1.8 $0.70 8/31/2023367,500 shares $319,725.00 -0.7%2.7%0.6 $0.87 8/15/2023370,200 shares $332,069.40 -1.3%2.8%0.8 $0.90 7/31/2023374,900 shares $371,151.00 +17.6%2.8%0.1 $0.99 7/15/2023318,700 shares $294,478.80 -32.2%2.4%0.1 $0.92 6/30/2023469,700 shares $413,805.70 -7.5%3.5%0.2 $0.88 6/15/2023507,600 shares $527,904.00 +14.9%4.7%0.2 $1.04 5/31/2023441,900 shares $503,766.00 -41.3%4.1%0.2 $1.14 5/15/2023752,700 shares $888,186.00 +341.2%7.1%0.3 $1.18 4/30/2023170,600 shares $110,548.80 +31.5%2.0%0.1 $0.65 4/15/2023129,700 shares $98,701.70 +142.9%1.6%1.2 $0.76 3/31/202353,400 shares $37,380.00 -57.3%0.6%0.5 $0.70 3/15/2023124,900 shares $106,727.05 +7.8%N/A1.3 $0.85 2/28/2023115,900 shares $125,172.00 -11.6%N/A1.3 $1.08 2/15/2023131,100 shares $153,387.00 +76.0%N/A1.5 $1.17 1/31/202374,500 shares $122,925.00 -16.8%N/A0.8 $1.65 1/15/202389,500 shares $182,580.00 -27.1%N/A1.1 $2.04 12/30/2022122,800 shares $175,604.00 +12.6%N/A1.7 $1.43 12/15/2022109,100 shares $169,105.00 -20.9%N/A1.9 $1.55 11/30/2022137,900 shares $476,444.50 -17.2%N/A2.8 $3.46 11/15/2022166,600 shares $576,436.00 -94.8%N/A4 $3.46 10/31/20223,180,000 shares $545,370.00 -1.2%N/A4.5 $0.17 10/15/20223,220,000 shares $590,548.00 -9.6%N/A3.7 $0.18 9/30/20223,560,000 shares $545,392.00 +3.8%N/A3.8 $0.15 9/15/20223,430,000 shares $703,150.00 -3.4%N/A2.6 $0.21**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! (Ad)Learn more about why Zack’s has increased its price target on this company to a whopping $23.25!Click for Zack's full report 8/31/20223,550,000 shares $766,445.00 +5.0%N/A2.2 $0.22 8/15/20223,380,000 shares $831,480.00 -8.2%N/A1.7 $0.25 7/31/20223,680,000 shares $913,008.00 +32.9%N/A1.8 $0.25 7/15/20222,770,000 shares $911,330.00 -2.1%1.7%1.4 $0.33 6/30/20222,830,000 shares $1.17 million -67.1%1.8%1.4 $0.41 6/15/20228,590,000 shares $3.56 million -3.5%11.2%3.9 $0.41 5/31/20228,900,000 shares $2.78 million +14.1%5.6%5.4 $0.31 5/15/20227,800,000 shares $1.58 million +10.2%4.9%6 $0.20 4/30/20227,080,000 shares $2.10 million +26.7%4.4%6.6 $0.30 4/15/20225,590,000 shares $2.24 million +21.3%3.5%5.5 $0.40 3/31/20224,610,000 shares $2.54 million +11.9%2.9%5 $0.55 3/15/20224,120,000 shares $1.70 million +14.4%2.6%5 $0.41 2/28/20223,600,000 shares $1.65 million -20.9%2.3%4.1 $0.46 2/15/20224,550,000 shares $2.31 million +2.5%2.9%4.5 $0.51 1/31/20224,440,000 shares $2.41 million -20.7%2.9%3.1 $0.54 1/15/20225,600,000 shares $3.34 million -22.5%3.6%3.8 $0.60 12/31/20217,230,000 shares $4.22 million -6.8%4.7%4.9 $0.58 12/15/20217,760,000 shares $5.38 million -13.2%5.0%5.2 $0.69 11/30/20218,940,000 shares $6.08 million -19.5%5.6%6.1 $0.68 11/15/202111,100,000 shares $9.44 million -14.5%7.0%8.2 $0.85 10/29/202112,980,000 shares $13.11 million -1.7%8.2%11 $1.01 10/15/202113,200,000 shares $15.05 million -7.0%8.3%11.3 $1.14 9/30/202114,190,000 shares $17.45 million -3.5%8.9%11 $1.23 9/15/202114,700,000 shares $17.93 million -1.3%9.3%7.9 $1.22 8/31/202114,900,000 shares $19.67 million +0.5%9.4%7.2 $1.32 8/13/202114,830,000 shares $18.98 million -16.0%9.3%6.6 $1.28 7/30/202117,650,000 shares $23.47 million -4.9%11.1%7.5 $1.33 7/15/202118,560,000 shares $28.21 million -6.9%11.7%6.9 $1.52 6/30/202119,940,000 shares $33.70 million +34.8%12.6%5.8 $1.69 6/15/202114,790,000 shares $29.88 million -4.4%9.5%4.8 $2.02 5/28/202115,470,000 shares $26.92 million +4.3%10.0%5.2 $1.74 5/14/202114,830,000 shares $21.65 million -17.8%N/A4.4 $1.46 4/30/202118,030,000 shares $31.01 million -10.4%N/A4.8 $1.72 4/15/202120,120,000 shares $34.41 million -1.1%N/A5.2 $1.71 3/31/202120,350,000 shares $36.83 million -2.0%N/A6.1 $1.81 3/15/202120,760,000 shares $44.84 million +10.8%N/A5.7 $2.16 2/26/202118,730,000 shares $41.02 million -0.5%N/A5.1 $2.19 2/12/202118,830,000 shares $51.59 million -14.4%N/A5.3 $2.74 1/29/202121,990,000 shares $48.16 million -0.8%N/A6.1 $2.19 1/15/202122,160,000 shares $48.31 million -10.4%N/A6.1 $2.18 12/31/202024,740,000 shares $52.94 million +7.7%N/A6.3 $2.14 12/15/202022,980,000 shares $50.33 million -1.3%N/A5.1 $2.19 11/30/202023,280,000 shares $59.83 million -1.6%N/A4.1 $2.57 11/15/202023,660,000 shares $63.88 million +29.0%N/A3.6 $2.70 10/30/202018,340,000 shares $46.95 million +15.5%N/A2.3 $2.56 10/15/202015,880,000 shares $45.26 million -8.4%N/A1.4 $2.85 9/30/202017,340,000 shares $51.85 million +16.9%N/A1.5 $2.99 9/15/202014,830,000 shares $31.51 million +8.9%N/A1.3 $2.13 8/31/202013,620,000 shares $24.11 million +21.9%N/A1.4 $1.77 8/14/202011,170,000 shares $26.03 million +29.6%N/A1.3 $2.33**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! (Ad)Learn more about why Zack’s has increased its price target on this company to a whopping $23.25!Click for Zack's full report 7/31/20208,620,000 shares $20.00 million +21.6%N/A1.2 $2.32 7/15/20207,090,000 shares $12.05 million +1.3%N/A2.2 $1.70 6/30/20207,000,000 shares $10.64 million +26.8%N/A2.5 $1.52 6/15/20205,520,000 shares $7.34 million +17.7%N/A2.2 $1.33 5/29/20204,690,000 shares $6.10 million -21.6%N/A2.4 $1.30 5/15/20205,980,000 shares $6.28 million +22.3%N/A3.4 $1.05 4/30/20204,890,000 shares $3.56 million +19.6%N/A3.7 $0.73 4/15/20204,090,000 shares $2.85 million +26.6%4.6%3.7 $0.70 3/31/20203,230,000 shares $2.20 million -21.7%3.7%4.2 $0.68 3/13/20204,127,400 shares $2.10 million +6.4%5.0%5.3 $0.51 2/28/20203,880,000 shares $2.33 million -14.2%4.7%6.1 $0.60 2/14/20204,520,000 shares $3.12 million +0.2%5.5%7.3 $0.69 1/31/20204,510,000 shares $3.16 million +3.7%5.4%7.6 $0.70 1/15/20204,350,000 shares $3.52 million +0.7%5.2%6.9 $0.81 12/31/20194,320,000 shares $4.19 million -2.3%5.2%7.8 $0.97 TRVN Short Interest - Frequently Asked Questions What is Trevena's current short interest? Short interest is the volume of Trevena shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 15,100 shares of TRVN short. 0.08% of Trevena's shares are currently sold short. Learn More on Trevena's current short interest. What is a good short interest percentage for Trevena? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.08% of Trevena's floating shares are currently sold short. Is Trevena's short interest increasing or decreasing? Trevena saw a drop in short interest in the month of April. As of April 30th, there was short interest totaling 15,100 shares, a drop of 74.4% from the previous total of 58,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Trevena's float size? Trevena currently has issued a total of 18,340,000 shares. Some of Trevena's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Trevena currently has a public float of 17,880,000 shares. How does Trevena's short interest compare to its competitors? 0.08% of Trevena's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Trevena: Vaxxinity, Inc. (3.61%), Bionomics Limited (1.45%), eFFECTOR Therapeutics, Inc. (3.12%), Oragenics, Inc. (2.07%), Virios Therapeutics, Inc. (1.24%), Cyclerion Therapeutics, Inc. (0.99%), Hepion Pharmaceuticals, Inc. (1.19%), Cadrenal Therapeutics, Inc. (0.80%), Shuttle Pharmaceuticals Holdings, Inc. (0.74%), Pasithea Therapeutics Corp. (1.34%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Trevena stock? Short selling TRVN is an investing strategy that aims to generate trading profit from Trevena as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Trevena? A short squeeze for Trevena occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TRVN, which in turn drives the price of the stock up even further. How often is Trevena's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TRVN, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: VAXX Short Squeeze BNOX Short Squeeze EFTR Short Squeeze OGEN Short Squeeze VIRI Short Squeeze CYCN Short Squeeze HEPA Short Squeeze CVKD Short Squeeze SHPH Short Squeeze KTTA Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TRVN) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersBill Gates is all about this tiny $2 stockTimothy SykesExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldNext President (Not Trump. Not Biden.)The Freeport SocietyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe #1 Crypto for AIWeiss RatingsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap Profits